These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26463822)

  • 61. Database searching for thymidine and thymidylate kinase inhibitors using three-dimensional structure-based methods.
    Manallack DT; Pitt WR; Herdewijn P; Balzarini J; De Clercq E; Sanderson MR; Sohi M; Wien F; Munier-Lehmann H; Haouz A; Delarue M
    J Enzyme Inhib Med Chem; 2002 Jun; 17(3):167-74. PubMed ID: 12443042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
    Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
    Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Discovery of 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection.
    Wang G; Deval J; Hong J; Dyatkina N; Prhavc M; Taylor J; Fung A; Jin Z; Stevens SK; Serebryany V; Liu J; Zhang Q; Tam Y; Chanda SM; Smith DB; Symons JA; Blatt LM; Beigelman L
    J Med Chem; 2015 Feb; 58(4):1862-78. PubMed ID: 25667954
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The rational of catalytic activity of herpes simplex virus thymidine kinase. a combined biochemical and quantum chemical study.
    Sulpizi M; Schelling P; Folkers G; Carloni P; Scapozza L
    J Biol Chem; 2001 Jun; 276(24):21692-7. PubMed ID: 11262392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
    Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
    Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.
    Larsson A; Oberg B; Alenius S; Hagberg CE; Johansson NG; Lindborg B; Stening G
    Antimicrob Agents Chemother; 1983 May; 23(5):664-70. PubMed ID: 6307131
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases.
    Hildebrand C; Sandoli D; Focher F; Gambino J; Ciarrocchi G; Spadari S; Wright G
    J Med Chem; 1990 Jan; 33(1):203-6. PubMed ID: 2153203
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between structural properties and affinity for herpes simplex virus type 1 thymidine kinase of bromine substituted 5-heteroaromatic 2'-deoxyuridines.
    Creuven I; Evrard C; Olivier A; Evrard G; Van Aerschot A; Wigerinck P; Herdewijn P; Durant F
    Antiviral Res; 1996 May; 30(2-3):63-74. PubMed ID: 8783799
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir.
    Bennett MS; Wien F; Champness JN; Batuwangala T; Rutherford T; Summers WC; Sun H; Wright G; Sanderson MR
    FEBS Lett; 1999 Jan; 443(2):121-5. PubMed ID: 9989588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of Stachyflin and its derivatives.
    Yagi S; Ono J; Yoshimoto J; Sugita K; Hattori N; Fujioka T; Fujiwara T; Sugimoto H; Hirano K; Hashimoto N
    Pharm Res; 1999 Jul; 16(7):1041-6. PubMed ID: 10450928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancing the aqueous solubility of d4T-based phosphoramidate prodrugs.
    Siddiqui A; McGuigan C; Ballatore C; Srinivasan S; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2000 Feb; 10(4):381-4. PubMed ID: 10714505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs.
    Dias CS; Anand BS; Mitra AK
    J Pharm Sci; 2002 Mar; 91(3):660-8. PubMed ID: 11920751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1.
    Tavakoli A; Ataei-Pirkooh A; Mm Sadeghi G; Bokharaei-Salim F; Sahrapour P; Kiani SJ; Moghoofei M; Farahmand M; Javanmard D; Monavari SH
    Nanomedicine (Lond); 2018 Nov; 13(21):2675-2690. PubMed ID: 30346253
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues.
    Al-Madhoun AS; Tjarks W; Eriksson S
    Mini Rev Med Chem; 2004 May; 4(4):341-50. PubMed ID: 15134537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New antiviral nucleoside prodrugs await application.
    Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
    Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and antiviral effect of phosphamide modified vidarabine for treating HSV 1 infections.
    Wang Z; Zang R; Niu Z; Wang W; Wang X; Tang Y
    Bioorg Med Chem Lett; 2021 Nov; 52():128405. PubMed ID: 34624489
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Antimicrob Agents Chemother; 1979 May; 15(5):723-9. PubMed ID: 230784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.